Journal
THERAPIE
Volume 76, Issue 4, Pages 369-+Publisher
ELSEVIER
DOI: 10.1016/j.therap.2021.05.007
Keywords
VaxZevria (R); Covid-19 vaccine; Pharmacovigilance; Atypical thrombosis; Thrombopenia; Anti-PF4 antibodies